← Study Library
In vitro · 2008
Preclinicalcounts toward this tierCalcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases
Troeberg L, Fushimi K, Khokha R, Emonard H, Ghosh P, Nagase H · FASEB Journal
Preclinicalcounts toward this tier
Calcium PPS blocked the aggrecan-degrading activity of ADAMTS-4 and ADAMTS-5 at IC50 values of 10–40 nM by binding their non-catalytic domains, raised TIMP-3 in porcine cartilage about 3.5-fold by blocking its receptor-mediated endocytosis rather than by raising transcription, and increased TIMP-3's affinity for the aggrecanases more than 100-fold. Cartilage from TIMP-3-null mice was markedly less protected, so the protection runs through TIMP-3 rather than through direct enzyme inhibition.
- Population
- Recombinant aggrecanases, porcine and human osteoarthritic cartilage explants, and cartilage from TIMP-3-null mice
- Intervention
- Calcium PPS at graded nanomolar concentrations
- Comparator
- Untreated enzyme and explant controls
- Limitations
- Enzyme, explant and cell work only, with no animal or human dosing. The inhibition is substrate-dependent — potent against aggrecan, weak against a non-glycosylated recombinant substrate. Tested the calcium salt rather than the sodium salt used clinically, supplied by Arthropharm, with Ghosh (PPS's developer) among the authors; the grants named in the acknowledgements are Wellcome Trust and NIH.
Cited by
1 entry references this study
- Pentosan polysulfate (PPS)PROM.
Peptides → Clinically studied
Evidence for that entry
Promising